ghk-cu bpc-157 tb-500 blend Recovery - Peptides for Inflammation Support Glow Peptides | GHK-Cu, BPC-157,

Vertigo snd balance issues light and noise sensitive

Known risks and important uncertainties BPC-157 does not have an approved product label defining contraindications, interactions, manufacturing specifications or a validated safety profile

In experimental stroke and reperfusion injury models, the peptide has been reported to reduce tissue damage and support recovery, possibly through improved cerebral blood flow and anti-inflammatory activity (7)

Ready to Optimize Your Health from the Inside Out

BPC-157: 0.25-0.5 mg daily subcutaneous TB-500: Loading phase 2.5 mg twice weekly for weeks 1-4, then maintenance 2-3 mg weekly Duration: 6-8 weeks concurrent use Note: Administer separately